Clinical trial
Nitric Oxide Inhalation Therapy for Myocardial Ischemia in Patients With Coronary Artery Disease
NCT00014040 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nitric Oxide Inhalation Therapy for Myocardial Ischemia in Patients With Coronary Artery Disease
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2001
- Completion date
- April 30, 2003
- Enrollment
- 25
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.